August 3, 2018 — Many publications lately have documented the possibility for obesity care and resulting weight loss to reverse type 2 diabetes. But it’s hardly a sure thing. So the question remains, how does this happen in some patients and not in others? A new study in Cell Metabolism offers some clues. Digging into Diabetes Remissions Late last […]
June 30, 2018 — New research in Lancet Planetary Health finds that air pollution is adding to the global burden of diabetes. In fact, researchers estimate that it contributed to 3.2 million new cases of type 2 diabetes in 2016 alone. Published yesterday, the study suggest that cuts in air pollution might help reverse global trends toward a crushing […]
June 16, 2018 — Yesterday, Michael Schwartz delivered this year’s Blackburn Lecture in Obesity Medicine. The lecture series honors both the memory of George Blackburn and individuals who have made extraordinary contributions to the science of obesity. Schwartz painted a remarkably clear picture of some complex neuroscience. Evidence is accumulating to describe the brain’s control center for diabetes and […]
March 24, 2018 — Maybe it’s not on the tip of every tongue. But serotonin is a bit more familiar than most neurotransmitters. Most people think of it as a “happy hormone” for the central nervous system that becomes depleted in a state of depression. However, The GI system has far more of it than the CNS. And now, […]
March 8, 2018 — Recent news makes it clear. You can be sure that relentless change lies ahead for type 2 diabetes care. The American College of Physicians (ACP, representing 152,000 internists) is fighting with the American Diabetes Association and other experts over the standard of care. And Scandinavian researchers have found that we might do well to split […]
February 23, 2018 — Wachet auf! As if the clues were not already present, an announcement yesterday makes it plain. Competitors in the sleepy diabesity market had best wake up. The first ever oral GLP-1 agonist for diabetes and obesity – semaglutide – is looking good in clinical trials. That means everyone else had better get serious about innovation. Or risk becoming […]
February 13, 2018 — An unfounded stigma surrounds weight loss surgery. This prejudice has its primary roots in forgivable ignorance about the reality of a body’s resistance to weight loss. A widespread view is that obesity is a chosen way of life, not an actual disease. The Pattern of a Disease The World Obesity Federation recently published a statement […]
December 8, 2017 — Sensational headlines have been hiding a serious story this week. NBC tells us that diet shakes and dropping sodas can reverse diabetes. But behind those headlines lies an important study and an even more important concept. Obesity care specialists and researchers are finding ways to reverse type 2 diabetes through better clinical care. To be […]
December 6, 2017 — Late yesterday, a new, once-weekly injection for type 2 diabetes cleared the hurdle of FDA approval for sale. Semaglutide, will be available early next year in a familiar pen injection device. It will come in two doses: 0.5 and 1.0 mg once weekly. For people with type 2 diabetes it’s great to have a once-weekly […]
October 27, 2017 — It’s been a reliable trope about type 2 diabetes for a long time. Supposedly, as much as a third of it goes undiagnosed. But a closer look says that finding more diagnoses of type 2 diabetes isn’t much of a problem any more. In Annals of Internal Medicine, Elizabeth Selvin and colleagues published a careful […]
